Share this post on:

Product Name :
UniPR-505

Search keywords :
UniPR505

drugId :
null

Target Vo:
Ephrin type-A receptor 2

Target Vo Short Name :
EphA2

Moa_Name:
Ephrin type-A receptor 2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Parma

Active Company_Name :
University Of Parma

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Golimumab Description
Phospho-Tau (Thr181) Rabbit mAb custom synthesis
Cytokeratin 19 Antibody (YA924): Cytokeratin 19 Antibody is an unconjugated, approximately 44 kDa, mouse-derived, anti-Cytokeratin 19 monoclonal antibody. Cytokeratin 19 Antibody can be used for: WB, IHC-P, IHC-F,ICC, IF expriments in human, mouse, rat background without labeling.

Share this post on:

Author: Interleukin Related